Literature DB >> 28801233

T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node.

Myriam Baratin1, Léa Simon2, Audrey Jorquera2, Clément Ghigo2, Doulaye Dembele3, Jonathan Nowak2, Rebecca Gentek2, Stephan Wienert4, Frederick Klauschen4, Bernard Malissen2, Marc Dalod2, Marc Bajénoff5.   

Abstract

In lymph nodes (LNs), dendritic cells (DCs) are thought to dispose of apoptotic cells, a function pertaining to macrophages in other tissues. We found that a population of CX3CR1+ MERTK+ cells located in the T cell zone of LNs, previously identified as DCs, are efferocytic macrophages. Lineage-tracing experiments and shield chimeras indicated that these T zone macrophages (TZM) are long-lived macrophages seeded in utero and slowly replaced by blood monocytes after birth. Imaging the LNs of mice in which TZM and DCs express different fluorescent proteins revealed that TZM-and not DCs-act as the only professional scavengers, clearing apoptotic cells in the LN T cell zone in a CX3CR1-dependent manner. Furthermore, similar to other macrophages, TZM appear inefficient in priming CD4 T cells. Thus, efferocytosis and T cell activation in the LN are uncoupled processes designated to macrophages and DCs, respectively, with implications to the maintenance of immune homeostasis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dendritic cell; efferocytosis; lymph node; macrophage

Mesh:

Substances:

Year:  2017        PMID: 28801233     DOI: 10.1016/j.immuni.2017.07.019

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  30 in total

1.  Negligible Role for Deletion Mediated by cDC1 in CD8+ T Cell Tolerance.

Authors:  Brendan W MacNabb; Douglas E Kline; Annie R Albright; Xiufen Chen; Daniel S Leventhal; Peter A Savage; Justin Kline
Journal:  J Immunol       Date:  2019-03-22       Impact factor: 5.422

2.  Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity.

Authors:  Mikhail Binnewies; Adriana M Mujal; Joshua L Pollack; Alexis J Combes; Emily A Hardison; Kevin C Barry; Jessica Tsui; Megan K Ruhland; Kelly Kersten; Marwan A Abushawish; Marko Spasic; Jonathan P Giurintano; Vincent Chan; Adil I Daud; Patrick Ha; Chun J Ye; Edward W Roberts; Matthew F Krummel
Journal:  Cell       Date:  2019-04-04       Impact factor: 41.582

3.  Lymphatic Endothelial Cells Are Essential Components of the Subcapsular Sinus Macrophage Niche.

Authors:  Isabelle Mondor; Myriam Baratin; Marine Lagueyrie; Lisa Saro; Sandrine Henri; Rebecca Gentek; Delphine Suerinck; Wolfgang Kastenmuller; Jean X Jiang; Marc Bajénoff
Journal:  Immunity       Date:  2019-04-30       Impact factor: 31.745

4.  Transcriptomic Analysis and High-dimensional Phenotypic Mapping of Mononuclear Phagocytes in Mesenteric Lymph Nodes Reveal Differences Between Ulcerative Colitis and Crohn's Disease.

Authors:  Laurence Chapuy; Marwa Bsat; Manuel Rubio; François Harvey; Vinicius Motta; Frank Schwenter; Ramses Wassef; Carole Richard; Colette Deslandres; Bich N Nguyen; Geneviève Soucy; Nir Hacohen; Jorge Fritz; Alexandra-Chloé Villani; Heena Mehta; Marika Sarfati
Journal:  J Crohns Colitis       Date:  2020-03-13       Impact factor: 9.071

5.  Lymph node stromal CCL2 limits antibody responses.

Authors:  Dragos C Dasoveanu; Hyeung Ju Park; Catherine L Ly; William D Shipman; Susan Chyou; Varsha Kumar; David Tarlinton; Burkhard Ludewig; Babak J Mehrara; Theresa T Lu
Journal:  Sci Immunol       Date:  2020-03-20

6.  Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells.

Authors:  Allison W Roberts; Bettina L Lee; Jacques Deguine; Shinu John; Mark J Shlomchik; Gregory M Barton
Journal:  Immunity       Date:  2017-11-14       Impact factor: 31.745

Review 7.  Efferocytosis in health and disease.

Authors:  Amanda C Doran; Arif Yurdagul; Ira Tabas
Journal:  Nat Rev Immunol       Date:  2019-12-10       Impact factor: 53.106

8.  Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity.

Authors:  Lauren B Rodda; Erick Lu; Mariko L Bennett; Caroline L Sokol; Xiaoming Wang; Sanjiv A Luther; Ben A Barres; Andrew D Luster; Chun Jimmie Ye; Jason G Cyster
Journal:  Immunity       Date:  2018-05-08       Impact factor: 31.745

9.  Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.

Authors:  Aude Chiot; Sakina Zaïdi; Charlène Iltis; Matthieu Ribon; Félix Berriat; Lorenzo Schiaffino; Ariane Jolly; Pierre de la Grange; Michel Mallat; Delphine Bohl; Stéphanie Millecamps; Danielle Seilhean; Christian S Lobsiger; Séverine Boillée
Journal:  Nat Neurosci       Date:  2020-10-19       Impact factor: 24.884

10.  Developmental cell programs are co-opted in inflammatory skin disease.

Authors:  Gary Reynolds; Peter Vegh; James Fletcher; Elizabeth F M Poyner; Emily Stephenson; Issac Goh; Rachel A Botting; Ni Huang; Bayanne Olabi; Anna Dubois; David Dixon; Kile Green; Daniel Maunder; Justin Engelbert; Mirjana Efremova; Krzysztof Polański; Laura Jardine; Claire Jones; Thomas Ness; Dave Horsfall; Jim McGrath; Christopher Carey; Dorin-Mirel Popescu; Simone Webb; Xiao-Nong Wang; Ben Sayer; Jong-Eun Park; Victor A Negri; Daria Belokhvostova; Magnus D Lynch; David McDonald; Andrew Filby; Tzachi Hagai; Kerstin B Meyer; Akhtar Husain; Jonathan Coxhead; Roser Vento-Tormo; Sam Behjati; Steven Lisgo; Alexandra-Chloé Villani; Jaume Bacardit; Philip H Jones; Edel A O'Toole; Graham S Ogg; Neil Rajan; Nick J Reynolds; Sarah A Teichmann; Fiona M Watt; Muzlifah Haniffa
Journal:  Science       Date:  2021-01-22       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.